Investigation of spectral performance for single-scan contrast-enhanced breast CT using photon-counting technology: A phantom study.

PURPOSE: Contrast-enhanced imaging of the breast is frequently used in breast MRI and has recently become more common in mammography. The purpose of this study was to make single-scan contrast-enhanced imaging feasible for photon-counting breast CT (pcBCT) and to assess the spectral performance of a pcBCT scanner by evaluating iodine maps and virtual non-contrast (VNC) images. METHODS: We optimized the settings of a pcBCT to maximize the signal-to-noise ratio between iodinated contrast agent and breast tissue. Therefore, an electronic energy threshold dividing the x-ray spectrum used into two energy bins was swept from 23.17 keV to 50.65 keV. Validation measurements were performed by placing syringes with contrast agent (2.5 mg/ml to 40 mg/ml) in phantoms with 7.5 cm and 12 cm in diameter. Images were acquired at different tube currents and reconstructed with 300 µm isotropic voxel size. Iodine maps and VNC images were generated using image-based material decomposition. Iodine concentrations and CT values were measured for each syringe and compared to the known concentrations and reference CT values. RESULTS: Maximal signal-to-noise ratios were found at a threshold position of 32.59 keV. Accurate iodine quantification (average root mean square error of 0.56 mg/ml) was possible down to a concentration of 2.5 mg/ml for all tube currents investigated. The enhancement has been sufficiently removed in the VNC images, so they can be interpreted as unenhanced CT images. Only minor changes of CT values compared to a conventional CT scan were observed. Noise was increased by the decomposition by a factor of 2.62 and 4.87 (7.5 cm and 12 cm phantoms) but did not compromise the accuracy of the iodine quantification. CONCLUSIONS: Accurate iodine quantification and generation of VNC images can be achieved using contrast-enhanced pcBCT from a single CT scan in the absence of temporal or spatial misalignment. Using iodine maps and VNC images, pcBCT has the potential to reduce dose, shorten examination and reading time, and to increase cancer detection rates.

Dedicated Breast Computed Tomography With a Photon-Counting Detector: Initial Results of Clinical In Vivo Imaging.

OBJECTIVES: The purpose of this work is to present the data obtained from the first clinical in vivo application of a new dedicated spiral breast computed tomography (B-CT) equipped with a photon-counting detector. MATERIALS AND METHODS: The institutional review board approved this retrospective study. Twelve women referred for breast cancer screening were included and underwent bilateral spiral B-CT acquired in prone position. Additional sonography was performed in case of dense breast tissue or any B-CT findings. In 3 women, previous mammography was available for comparison. Soft tissue (ST) and high-resolution (HR) images were reconstructed. Two independent radiologists performed separately the readout for subjective image quality and for imaging findings detection. Objective image quality evaluation was performed in consensus and included spatial resolution, contrast resolution, signal-to-noise ratio (SNR), and contrast-to-noise ratio. All women were asked to report about positioning comfort and overall comfort during data acquisition. RESULTS: The major pectoral muscle was included in 15 breast CT scans (62.5%); glandular component was partially missing in 2 (8.3%) of the 24 scanned breasts. A thin "ring artifact" was present in all scans but had no influence on image interpretations; no other artifacts were present. Subjective image quality assessment showed excellent agreement between the 2 readers (κ = 1). Three masses were depicted in B-CT and were confirmed as simple cysts in sonography. Additional 5 simple cysts and 2 solid benign lesions were identified only in sonography. A total of 12 calcifications were depicted with a median size of 1.1 mm (interquartile range, 0.7-1.7 mm) on HR and 1.4 mm (interquartile range, 1.1-1.8 mm) on ST images. Median SNRgl, SNRfat, and contrast-to-noise ratio were significantly higher in ST than in HR reconstructions (each, P < 0.001). A mild discomfort due to positioning of the rib cage on the table was reported by 2 women (16.7%); otherwise, no discomfort was reported. CONCLUSIONS: The new dedicated B-CT equipped with a photon-counting detector provides high-quality images with potential for screening of breast cancer along with minor patient discomfort.

Metal Artifact Reduction in X-ray Computed Tomography Using Computer-Aided Design Data of Implants as Prior Information.

OBJECTIVES: The performance of metal artifact reduction (MAR) methods in x-ray computed tomography (CT) suffers from incorrect identification of metallic implants in the artifact-affected volumetric images. The aim of this study was to investigate potential improvements of state-of-the-art MAR methods by using prior information on geometry and material of the implant. MATERIALS AND METHODS: The influence of a novel prior knowledge-based segmentation (PS) compared with threshold-based segmentation (TS) on 2 MAR methods (linear interpolation [LI] and normalized-MAR [NORMAR]) was investigated. The segmentation is the initial step of both MAR methods. Prior knowledge-based segmentation uses 3-dimensional registered computer-aided design (CAD) data as prior knowledge to estimate the correct position and orientation of the metallic objects. Threshold-based segmentation uses an adaptive threshold to identify metal. Subsequently, for LI and NORMAR, the selected voxels are projected into the raw data domain to mark metal areas. Attenuation values in these areas are replaced by different interpolation schemes followed by a second reconstruction. Finally, the previously selected metal voxels are replaced by the metal voxels determined by PS or TS in the initial reconstruction. First, we investigated in an elaborate phantom study if the knowledge of the exact implant shape extracted from the CAD data provided by the manufacturer of the implant can improve the MAR result. Second, the leg of a human cadaver was scanned using a clinical CT system before and after the implantation of an artificial knee joint. The results were compared regarding segmentation accuracy, CT number accuracy, and the restoration of distorted structures. RESULTS: The use of PS improved the efficacy of LI and NORMAR compared with TS. Artifacts caused by insufficient segmentation were reduced, and additional information was made available within the projection data. The estimation of the implant shape was more exact and not dependent on a threshold value. Consequently, the visibility of structures was improved when comparing the new approach to the standard method. This was further confirmed by improved CT value accuracy and reduced image noise. CONCLUSIONS: The PS approach based on prior implant information provides image quality which is superior to TS-based MAR, especially when the shape of the metallic implant is complex. The new approach can be useful for improving MAR methods and dose calculations within radiation therapy based on the MAR corrected CT images.

Technical feasibility proof for high-resolution low-dose photon-counting CT of the breast.

X-ray computed tomography (CT) has been proposed and evaluated multiple times as a potentially alternative method for breast imaging. All efforts shown so far have been criticized and partly disapproved because of their limited spatial resolution and higher patient dose when compared to mammography. Our concept for a dedicated breast CT (BCT) scanner therefore aimed at novel apparatus and detector design to provide high spatial resolution of about 100 µm and average glandular dose (AGD) levels of 5 mGy or below. Photon-counting technology was considered as a solution to reach these goals. The complete concept was previously evaluated and confirmed by simulations and basic experiments on laboratory setups. We here present measurements of dose, technical image quality parameters and surgical specimen results on such a scanner. For comparison purposes, the specimens were also imaged with digital mammography (DM) and breast tomosynthesis (BT) apparatus. Results show that photon-counting BCT (pcBCT) at 5 mGy AGD offers sufficiently high 3D spatial resolution for reliable detectability of calcifications and soft tissue delineation. KEY POINTS: • Photon-counting detector technology allows for spatial resolution better than 100 µm. • pcBCT allows for dose levels in the screening mammography range. • pcBCT provides the highest quality imaging of microcalcifications.

Dose Optimization for Computed Tomography Localizer Radiographs for Low-Dose Lung Computed Tomography Examinations.

INTRODUCTION: Recent studies have shown a substantial reduction of radiation dose from computed tomography (CT) scans down to 0.1 mSv for lung cancer screening and cardiac examinations, when applying optimization techniques. Hence, CT localizer radiographs (LRs) might now be considered a significant contributor to the total dose of the CT examination. We investigated in our study the potential for reducing dose of the LRs by adapting the patient-specific acquisition parameters of the LR. MATERIALS AND METHODS: Localizer radiographs covering the lungs were acquired on 2 clinical scanners (64 slices, conventional detector [CD]; 96 slices, fully integrated detector [ID]) for 3 semianthropomorphic phantoms, representing a slim, a normal, and an obese adult. Starting at 120-kV tube voltage and 250-mA current were reduced until the image quality of the LR, and thereby the accuracy of the automatic exposure control was compromised; this was defined as a deviation of measured attenuation values in the center of the LR of more than 5% from the reference values measured at the highest tube voltage and current. Subsequent Monte Carlo calculations on anthropomorphic phantoms were performed to calculate organ and effective dose values for the respective optimal settings. In addition, effective dose values normalized to CTDIvol for tube voltages ranging from 60 to 160 kV were determined for the different combinations of phantom sizes, sexes, and LR views to evaluate dose efficiency. RESULTS: For the CD scanner, the optimal LR settings depended strongly on phantom size. Higher tube voltage and current were necessary for the larger phantoms. The ID scanner showed uncompromised LR quality for all phantoms using the lowest possible tube voltage-tube current combination of 80 kV and 20 mA. Depending on patient size and LR direction, effective dose values for the optimal settings ranged from 6 to 53 µSv and 3 to 11 µSv for the CD and ID scanner, respectively. For the example of an anterior-posterior LR on a normal patient, using the optimal settings instead of the standard settings on the ID scanner reduced LR dose from 53 µSv (120 kV, 30 mA) to 10 µSv (80 kV, 20 mA). The simulations for the different tube voltages show that effective dose and CTDIvol behave similarly for different views and patient sizes. However, the tube voltage level itself impacts the relationship between CTDIvol and effective dose, by up to a factor of 2. DISCUSSION: Dose from LRs may contribute significantly to the total effective dose of low-dose CT examinations such as lung cancer screening. Optimal LR settings can reduce LR dose substantially, but adaptations have to consider scanner characteristics, detector technology, and patient size. Thus, for low-dose CT examinations, such as cardiac examinations and lung cancer screening, LR optimization may result in a significant dose reduction and thereby in a substantial reduction of total dose.

Securing safe and informative thoracic CT examinations-Progress of radiation dose reduction techniques.

The increase in the radiation exposure from CT examinations prompted the investigation on the various dose-reduction techniques. Significant dose reduction has been achieved and the level of radiation exposure of thoracic CT is expected to reach the level equivalent to several chest X-ray examinations. With more scanners with advanced dose reduction capability deployed, knowledge on the radiation dose reduction methods has become essential to clinical practice as well as academic research. This article reviews the history of dose reduction techniques, ongoing changes brought by newer technologies and areas of further investigation.

High Atomic Number Contrast Media Offer Potential for Radiation Dose Reduction in Contrast-Enhanced Computed Tomography.

OBJECTIVES: Spectral optimization of x-ray computed tomography (CT) has led to substantial radiation dose reduction in contrast-enhanced CT studies using standard iodinated contrast media. The purpose of this study was to analyze the potential for further dose reduction using high-atomic-number elements such as hafnium and tungsten. As in previous studies, spectra were determined for which the patient dose necessary to provide a given contrast-to-noise ratio (CNR) is minimized. MATERIALS AND METHODS: We used 2 different quasi-anthropomorphic phantoms representing the liver cross-section of a normal adult and an obese adult patient with the lateral widths of 360 and 460 mm and anterior-posterior heights of 200 and 300 mm, respectively. We simulated and measured on 2 different scanners with x-ray spectra from 80 to 140 kV and from 70 to 150 kV, respectively. We determined the contrast for iodine-, hafnium-, and tungsten-based contrast media, the noise, and 3-dimensional dose distributions at all available tube voltages by measurements and by simulations. The dose-weighted CNR was determined as optimization parameter. RESULTS: Simulations and measurements were in good agreement regarding their dependence on energy for all parameters investigated. Hafnium provided the best performance for normal and for obese patient phantoms, indicating a dose reduction potential of 30% for normal and 50% for obese patients at 120 kV compared with iodine; this advantage increased further with higher kV values. Dose-weighted CNR values for tungsten were always slightly below the hafnium results. Iodine proved to be the superior choice at voltage values of 80 kV and below. DISCUSSION: Hafnium and tungsten both seem to be candidates for contrast-medium-enhanced CT of normal and obese adult patients with strongly reduced radiation dose at unimpaired image quality. Computed tomography examinations of obese patients will decrease in dose for higher kV values.

Screening for breast cancer with Breast-CT in a ProHTA simulation.

AIMS: The potential of dedicated Breast-CT is evaluated by simulating its impact onto the performance of the German breast cancer screening program. Attendance rates, cancer detection and economic implications are quantified. METHODS: Based on a prospective health technology assessment approach, we simulated screening in different scenarios. RESULTS: In the simulation, attendance rates increase from 54 to up to 72% due to reduced pain. Breast cancers will be detected earlier while nodal positives and distant recurrences decrease. Assuming no additional cost, cost savings of up to €55 million in one screening period are computed. CONCLUSION: The simulation indicates that earlier cancer detection, fewer unnecessary biopsies and less pain are potential benefits of Breast-CT resulting in cost savings and higher attendance.

Comparative investigation of the detective quantum efficiency of direct and indirect conversion detector technologies in dedicated breast CT.

PURPOSE: To investigate the dose saving potential of direct-converting CdTe photon-counting detector technology for dedicated breast CT. MATERIALS AND METHODS: We analyzed the modulation transfer function (MTF), the noise power spectrum (NPS) and the detective quantum efficiency (DQE) of two detector technologies, suitable for breast CT (BCT): a flat-panel energy-integrating detector with a 70 µm and a 208 µm thick gadolinium oxysulfide (GOS) and a 150 µm thick cesium iodide (CsI) scintillator and a photon-counting detector with a 1000 µm thick CdTe sensor. RESULTS: The measurements for GOS scintillator thicknesses of 70 µm and 208 µm delivered 10% pre-sampled MTF values of 6.6 mm(-1) and 3.2 mm(-1), and DQE(0) values of 23% and 61%. The 10% pre-sampled MTF value for the 150 µm thick CsI scintillator 6.9 mm(-1), and the DQE(0) value was 49%. The CdTe sensor reached a 10% pre-sampled MTF value of 8.5 mm(-1) and a DQE(0) value of 85%. CONCLUSION: The photon-counting CdTe detector technology allows for significant dose reduction compared to the energy-integrating scintillation detector technology used in BCT today. Our comparative evaluation indicates that a high potential dose saving may be possible for BCT by using CdTe detectors, without loss of spatial resolution.

Registration of 2D histological sections with 3D micro-CT datasets from small animal vertebrae and tibiae.

The aim of this study was the registration of digitized thin 2D sections of mouse vertebrae and tibiae used for histomorphometry of trabecular bone structure into 3D micro computed tomography (µCT) datasets of the samples from which the sections were prepared. Intensity-based and segmentation-based registrations (SegRegs) of 2D sections and 3D µCT datasets were applied. As the 2D sections were deformed during their preparation, affine registration for the vertebrae was used instead of rigid registration. Tibiae sections were additionally cut on the distal end, which subsequently undergone more deformation so that elastic registration was necessary. The Jaccard distance was used as registration quality measure. The quality of intensity-based registrations and SegRegs was practically equal, although precision errors of the elastic registration of segmentation masks in tibiae were lower, while those in vertebrae were lower for the intensity-based registration. Results of SegReg significantly depended on the segmentation of the µCT datasets. Accuracy errors were reduced from approximately 64% to 42% when applying affine instead of rigid transformations for the vertebrae and from about 43% to 24% when using B-spline instead of rigid transformations for the tibiae. Accuracy errors can also be caused by the difference in spatial resolution between the thin sections (pixel size: 7.25 µm) and the µCT data (voxel size: 15 µm). In the vertebrae, average deformations amounted to a 6.7% shortening along the direction of sectioning and a 4% extension along the perpendicular direction corresponding to 0.13-0.17 mm. Maximum offsets in the mouse tibiae were 0.16 mm on average.

Characterization of knee osteoarthritis-related changes in trabecular bone using texture parameters at various levels of spatial resolution-a simulation study.

Articular cartilage and subchondral bone are the key tissues in osteoarthritis (OA). The role of the cancellous bone increasingly attracts attention in OA research. Because of its fast adaptation to changes in the loading distribution across joints, its quantification is expected to improve the diagnosis and monitoring of OA. In this study, we simulated OA progression-related changes of trabecular structure in a series of digital bone models and then characterized the potential of texture parameters and bone mineral density (BMD) as surrogate measures to quantify trabecular bone structure. Five texture parameters were studied: entropy, global and local inhomogeneity, anisotropy and variogram slope. Their dependence on OA relevant structural changes was investigated for three spatial resolutions typically used in micro computed tomography (CT; 10 µm), high-resolution peripheral quantitative CT (HR-pQCT) (90 µm) and clinical whole-body CT equipment (250 µm). At all resolutions, OA-related changes in trabecular bone architecture can be quantified using a specific (resolution dependent) combination of three texture parameters. BMD alone is inadequate for this purpose but if available reduces the required texture parameter combination to anisotropy and global inhomogeneity. The results are summarized in a comprehensive analysis guide for the detection of structural changes in OA knees. In conclusion, texture parameters can be used to characterize trabecular bone architecture even at spatial resolutions below the dimensions of a single trabecula and are essential for a detailed classification of relevant OA changes that cannot be achieved with a measurement of BMD alone.

Generating and using patient-specific whole-body models for organ dose estimates in CT with increased accuracy: feasibility and validation.

The estimation of patient dose using Monte Carlo (MC) simulations based on the available patient CT images is limited to the length of the scan. Software tools for dose estimation based on standard computational phantoms overcome this problem; however, they are limited with respect to taking individual patient anatomy into account. The purpose of this study was to generate whole-body patient models in order to take scattered radiation and over-scanning effects into account. Thorax examinations were performed on three physical anthropomorphic phantoms at tube voltages of 80 kV and 120 kV; absorbed dose was measured using thermoluminescence dosimeters (TLD). Whole-body voxel models were built as a combination of the acquired CT images appended by data taken from widely used anthropomorphic voxel phantoms. MC simulations were performed both for the CT image volumes alone and for the whole-body models. Measured and calculated dose distributions were compared for each TLD chip position; additionally, organ doses were determined. MC simulations based only on CT data underestimated dose by 8%-15% on average depending on patient size with highest underestimation values of 37% for the adult phantom at the caudal border of the image volume. The use of whole-body models substantially reduced these errors; measured and simulated results consistently agreed to better than 10%. This study demonstrates that combined whole-body models can provide three-dimensional dose distributions with improved accuracy. Using the presented concept should be of high interest for research studies which demand high accuracy, e.g. for dose optimization efforts.

Experimental validation of a single shaped filter approach for CT using variable source-to-filter distance for examination of arbitrary object diameters.

The purpose of this study was to validate the use of a single shaped filter (SF) for computed tomography (CT) using variable source-to-filter distance (SFD) for the examination of different object diameters.A SF was designed by performing simulations with the purpose of achieving noise homogeneity in the reconstructed volume and dose reduction for arbitrary phantom diameters. This was accomplished by using a filter design method thats target is to achieve a homogeneous detector noise, but also uses a correction factor for the filtered back projection process. According to simulation results, a single SF designed for one of the largest phantom diameters meets the requirements for all diameters when SFD can be adjusted. To validate these results, a SF made of aluminium alloy was manufactured. Measurements were performed on a CT scanner with polymethyl methacrylate (PMMA) phantoms of diameters from 40-100 mm. The filter was positioned at SFDs ranging from 97-168 mm depending on the phantom diameter. Image quality was evaluated for the reconstructed volume by assessing CT value accuracy, noise homogeneity, contrast-to-noise ratio weighted by dose (CNRD) and spatial resolution. Furthermore, scatter distribution was determined with the use of a beam-stop phantom. Dose was measured for a PMMA phantom with a diameter of 100 mm using a calibrated ionization chamber.The application of a single SF at variable SFD led to improved noise uniformity and dose reduction: noise homogeneity was improved from 15% down to about 0%, and dose was reduced by about 37%. Furthermore, scatter dropped by about 32%, which led to reduced cupping artifacts and improved CT value accuracy. Spatial resolution and CNRD was not affected by the SF.By means of a single SF with variable SFD designed for CT, significant dose reduction can be achieved and image quality can be improved by reducing noise inhomogeneity as well as scatter-induced artifacts.

Estimates of effective dose for CT scans of the lower extremities.

PURPOSE: To determine the dose-length product (DLP)-effective dose (ED) (DLP/ED) conversion coefficient (k) tables for the lower extremities that can be used for calculating ED. MATERIALS AND METHODS: Dose calculations were performed on standard phantoms using a validated Monte Carlo calculation tool. Calculations were performed to obtain ED values for tube voltages from 80 kV to 140 kV in steps of 20 kV for the following examinations: hip (femur), knee, ankle, and computed tomographic (CT) angiography of the lower extremities. Values of the DLP were calculated by multiplying measured CT dose index values by the scan length; k values resulted as the quotients of the ED and DLP values. DLP/ED coefficients averaged over the range of voltage values and their standard deviations were determined for the given lower-extremity CT examinations for all age groups and for both sexes. RESULTS: Coefficients depend strongly on the phantom age and size, but little on the kilovolt value. In the case of the newborn, for example, k values were 0.0612, 0.0046, 0.0014, and 0.047 for hip, knee, ankle, and CT angiography, respectively, while in the case of the adult, these respective values were 0.0110, 0.0004, 0.0002, and 0.0062. A substantial difference up to 20% between coefficients in male and female phantoms was observed for CT angiographic examination. CONCLUSION: DLP/ED conversion coefficients are provided for lower extremities and allow estimation of ED for commonly used clinical musculoskeletal CT and CT angiographic protocols.

Dynamic contrast-enhanced micro-computed tomography correlates with 3-dimensional fluorescence ultramicroscopy in antiangiogenic therapy of breast cancer xenografts.

OBJECTIVES: Dynamic contrast-enhanced (DCE) micro-computed tomography (micro-CT) has emerged as a valuable imaging tool to noninvasively obtain quantitative physiological biomarkers of drug effect in preclinical studies of antiangiogenic compounds. In this study, we explored the ability of DCE micro-CT to assess the antiangiogenic treatment response in breast cancer xenografts and correlated the results to the structural vessel response obtained from 3-dimensional (3D) fluorescence ultramicroscopy (UM). MATERIAL AND METHODS: Two groups of tumor-bearing mice (KPL-4) underwent DCE micro-CT imaging using a fast preclinical dual-source micro-CT system (TomoScope Synergy Twin, CT Imaging GmbH, Erlangen, Germany). Mice were treated with either a monoclonal antibody against the vascular endothelial growth factor or an unspecific control antibody. Changes in vascular physiology were assessed measuring the mean value of the relative blood volume (rBV) and the permeability-surface area product (PS) in different tumor regions of interest (tumor center, tumor periphery, and total tumor tissue). Parametric maps of rBV were calculated of the tumor volume to assess the intratumoral vascular heterogeneity. Isotropic 3D UM vessel scans were performed from excised tumor tissue, and automated 3D segmentation algorithms were used to determine the microvessel density (MVD), relative vessel volume, and vessel diameters. In addition, the accumulation of coinjected fluorescence-labeled trastuzumab was quantified in the UM tissue scans to obtain an indirect measure of vessel permeability. Results of the DCE micro-CT were compared with corresponding results obtained by ex vivo UM. For validation, DCE micro-CT and UM parameters were compared with conventional histology and tumor volume. RESULTS: Examination of the parametric rBV maps revealed significantly different patterns of intratumoral blood supply between treated and control tumors. Whereas control tumors showed a characteristic vascular rim pattern with considerably elevated rBV values in the tumor periphery, treated tumors showed a widely homogeneous blood supply. Compared with UM, the physiological rBV maps showed excellent agreement with the spatial morphology of the intratumoral vascular architecture. Regional assessment of mean physiological values exhibited a significant decrease in rBV (P < 0.01) and PS (P < 0.05) in the tumor periphery after anti-vascular endothelial growth factor treatment. Structural validation with UM showed a significant reduction in reduction of relative vessel volume (rVV) (P < 0.01) and MVD (P < 0.01) in the corresponding tumor region. The reduction in rBV correlated well with the rVV (R = 0.73 for single values and R = 0.95 for mean values). Spatial maps of antibody penetration showed a significantly reduced antibody accumulation (P < 0.01) in the tumor tissue after treatment and agreed well with the physiological change of PS. Examination of vessel diameters revealed a size-dependent antiangiogenic treatment effect, which showed a significant reduction in MVD (P < 0.001) for vessels with diameters smaller than 25 µm. No treatment effect was observed by tumor volume. CONCLUSIONS: Noninvasive DCE micro-CT provides valuable physiological information of antiangiogenic drug effect in the intact animal and correlates with ex vivo structural analysis of 3D UM. The combined use of DCE micro-CT with UM constitutes a complementary imaging toolset that can help to enhance our understanding of antiangiogenic drug mechanisms of action in preclinical drug research.

A quality assurance framework for the fully automated and objective evaluation of image quality in cone-beam computed tomography.

PURPOSE: Thousands of cone-beam computed tomography (CBCT) scanners for vascular, maxillofacial, neurological, and body imaging are in clinical use today, but there is no consensus on uniform acceptance and constancy testing for image quality (IQ) and dose yet. The authors developed a quality assurance (QA) framework for fully automated and time-efficient performance evaluation of these systems. In addition, the dependence of objective Fourier-based IQ metrics on direction and position in 3D volumes was investigated for CBCT. METHODS: The authors designed a dedicated QA phantom 10 cm in length consisting of five compartments, each with a diameter of 10 cm, and an optional extension ring 16 cm in diameter. A homogeneous section of water-equivalent material allows measuring CT value accuracy, image noise and uniformity, and multidimensional global and local noise power spectra (NPS). For the quantitative determination of 3D high-contrast spatial resolution, the modulation transfer function (MTF) of centrally and peripherally positioned aluminum spheres was computed from edge profiles. Additional in-plane and axial resolution patterns were used to assess resolution qualitatively. The characterization of low-contrast detectability as well as CT value linearity and artifact behavior was tested by utilizing sections with soft-tissue-equivalent and metallic inserts. For an automated QA procedure, a phantom detection algorithm was implemented. All tests used in the dedicated QA program were initially verified in simulation studies and experimentally confirmed on a clinical dental CBCT system. RESULTS: The automated IQ evaluation of volume data sets of the dental CBCT system was achieved with the proposed phantom requiring only one scan for the determination of all desired parameters. Typically, less than 5 min were needed for phantom set-up, scanning, and data analysis. Quantitative evaluation of system performance over time by comparison to previous examinations was also verified. The maximum percentage interscan variation of repeated measurements was less than 4% and 1.7% on average for all investigated quality criteria. The NPS-based image noise differed by less than 5% from the conventional standard deviation approach and spatially selective 10% MTF values were well comparable to subjective results obtained with 3D resolution pattern. Determining only transverse spatial resolution and global noise behavior in the central field of measurement turned out to be insufficient. CONCLUSIONS: The proposed framework transfers QA routines employed in conventional CT in an advanced version to CBCT for fully automated and time-efficient evaluation of technical equipment. With the modular phantom design, a routine as well as an expert version for assessing IQ is provided. The QA program can be used for arbitrary CT units to evaluate 3D imaging characteristics automatically.

Dose in x-ray computed tomography.

Radiation dose in x-ray computed tomography (CT) has become a topic of high interest due to the increasing numbers of CT examinations performed worldwide. This review aims to present an overview of current concepts for both scanner output metrics and for patient dosimetry and will comment on their strengths and weaknesses. Controversial issues such as the appropriateness of the CT dose index (CTDI) are discussed in detail. A review of approaches to patient dose assessment presently in practice, of the dose levels encountered and options for further dose optimization are also given and discussed. Patient dose assessment remains a topic for further improvement and for international consensus. All approaches presently in use are based on Monte Carlo (MC) simulations. Estimates for effective dose are established, but they are crude and not patient-specific; organ dose estimates are rarely available. Patient- and organ-specific dose estimates can be provided with adequate accuracy and independent of CTDI phantom measurements by fast MC simulations. Such information, in particular on 3D dose distributions, is important and helpful in optimization efforts. Dose optimization has been performed very successfully in recent years and even resulted in applications with effective dose values of below 1 mSv. In general, a trend towards lower dose values based on technical innovations has to be acknowledged. Effective dose values are down to clearly below 10 mSv on average, and there are a number of applications such as cardiac and pediatric CT which are performed routinely below 1 mSv on modern equipment.

Assessment of patient dose from CT localizer radiographs.

PURPOSE: With recently introduced technical innovations for CT systems, the dose of CT scan acquisitions has been substantially reduced; even effective dose values below 1 mSv have been reported. Due to this development, dose of the localizer radiograph may contribute substantially to dose of the whole CT examination. Since there are only limited data in the literature regarding patient dose for the different types of localizer radiographs, patient dose values were estimated in our study by measurements and Monte Carlo simulations and compared to dose values of typical CT examinations. METHODS: First, dose distributions were measured in anthropomorphic phantoms for three different body regions (head, thorax, abdomen-pelvic) and three positions of the x-ray tube (AP, PA, and lateral views); measured values were compared to simulated data using Monte Carlo techniques for validation purposes. Second, organ and effective dose values for the various investigated localizer radiograph scenarios were calculated and compared with published dose values for standard CT and low-dose CT examinations. RESULTS: For the anthropomorphic phantom, deviations of the dose values between measured and calculated results were in the range of 15%. Organ and effective dose values showed a strong dependence on the tube position. The largest differences were observed for chest localizer radiographs in the female phantom for the dose to the breast (AP: 1.01 mGy vs PA: 0.24 mGy). Overall effective dose values were in the range of 0.04-0.42 mSv per localizer radiograph acquisition. CONCLUSIONS: In view of the technical dose-reducing innovations in CT, localizer radiographs may substantially contribute to the total dose of the whole CT examination, particularly in the case of dedicated low-dose scans used, e.g., for young patients or screening purposes. Optimization of dose in localizer radiographs should be pursued further in the same way as it was done in CT.

Long-term exercise and risk of metabolic and cardiac diseases: the erlangen fitness and prevention study.

In female subjects, ageing and the menopausal transition contribute to a rapid increase of metabolic and cardiac risk factors. Exercise may be an option to positively impact various risk factors prone to severe metabolic and cardiac diseases and events. This study was conducted to determine the long-term effect of a multipurpose exercise program on metabolic and cardiac risk scores in postmenopausal women. 137 osteopenic Caucasian females (55.4 ± 3.2 yrs), 1-8 years postmenopausal, were included in the study. Eighty-six subjects joined the exercise group (EG) and performed an intense multipurpose exercise program which was carefully supervised during the 12-year period, while 51 females maintained their habitual physical activity (CG). Main outcome measures were 10-year coronary heart disease risk (10 y CHD risk), metabolic syndrome Z-score (MetS Index), and 10-year myocardial infarction risk (10 y hard CHD risk). Significant between-group differences all in favor of the EG were determined for 10 y-CHD risk (EG: 2.65 ± 2.09% versus CG: 5.40 ± 3.30%; P = 0.001), MetS-Index (EG: -0.42 ± 1.03% versus CG: 1.61 ± 1.88; P = 0.001), and 10 y-hard-CHD risk (EG: 2.06 ± 1.17% versus CG: 3.26 ± 1.31%; P = 0.001). Although the nonrandomized design may prevent definite evidence, the intense multi-purpose exercise program determined the long-term efficacy and feasibility of an exercise program to significantly impact metabolic and cardiac risk scores in postmenopausal women. This trial is registered with ClinicalTrials.gov NCT01177761.

Effect of shaped filter design on dose and image quality in breast CT.

The purpose of this study was to investigate the effect of shaped filters specifically designed for dedicated breast computed tomography (CT) scanners on dose and image quality. Optimization of filter shape and material in fan direction was performed using two different design methods, one aiming at homogeneous noise distributions in the CT images and the other aiming at a uniform dose distribution in the breast. The optimal filter thickness as a function of fan angle was determined iteratively to fulfil the above mentioned criteria for each breast diameter. Different filter materials (aluminium, copper, carbon, polytetrafluoroethylene) and breast phantoms with diameters between 80-180 mm were investigated. Noise uniformity in the reconstructed images, obtained from CT simulations based on ray-tracing methods, and dose in the breast, calculated with a Monte Carlo software tool, were used as figure of merit. Furthermore, CT-value homogeneity, the distribution of noise in cone direction, spatial resolution from centre to periphery and the contrast-to-noise ratio weighted by dose (CNRD) were evaluated. In addition, the decrease of scatter due to shaped filters was investigated. Since only few or one filter are practical in clinical CT systems, the effects of one shaped filter for different breast diameters were also investigated. In this case the filter, designed for the largest breast diameter, was simulated at variable source-to-filter distances depending on breast diameter. With the filter design method aiming at uniform noise distribution best results were obtained for aluminium as the filter material. Noise uniformity improved from 20} down to 5} and dose was reduced by about 30-40} for all breast diameters. No decrease of noise uniformity in cone direction, CT-value homogeneity, spatial resolution and the CNRD was detected with the shaped filter. However, a small improvement of CNRD was observed. Furthermore, a scatter reduction of about 20-30} and a more homogeneous scatter distribution were reached which led to reduced cupping artefacts. The simulations with one shaped filter at variable source-to-filter distance resulted in nearly homogeneous noise distributions and comparable dose reduction for all breast diameters. In conclusion, by means of shaped filters designed for breast CT, significant dose reduction can be achieved at unimpaired image quality. One shaped filter designed for the largest breast diameter used with variable source-to-filter distance appears to be the best solution for breast CT.